Pain and Palliative Care



Pain and Palliative Care





PRINCIPLES OF PALLIATIVE MEDICINE

Rebecca T. Armendariz

Stacy M. Stabler


What is Palliative Care?



  • Definition: Palliative medicine is a specialized medical care for people w/serious or life-threatening illnesses. It improves the QoL of pts & their families by focusing on tx of pain & other physical sx as well as relief of the psychosocial & spiritual distress that comes w/a dx of a serious illness.


  • The palliative care IDT includes physicians, nurse practitioners, nurses, pharmacists, social workers, case managers, psychiatrists, psychologists, & spiritual care counselors who work together w/the pt’s doctor(s) to provide an extra layer of support


  • Palliative care is appropriate at any age & at any stage of a serious illness & can be provided along w/curative or palliative tx in an outpatient clinic, hospital, nursing home, skilled facility, or at a pt’s home


  • Hospice care is a delivery system that provides palliative care to terminally ill pts

    (usu <6 mos life expectancy) in the home, nursing home, or inpt facility


The Palliative Care Consult



  • Request a palliative care consult for assistance w/pain & sx management, advance directives, capacity assessment, establishing GOC, breaking bad news, prognostication, withdrawal of life-sustaining tx, disposition planning, addressing end-of-life nutritional support, initiating family meetings, identifying existential distress, addressing spiritual & cross-cultural issues, making appropriate hospice referrals & evaluation for bereavement care


Core Principles for End-of-Life Care



  • Assessment is focused on what the pt feels are the most important sx/issues that they need assistance w/


  • Respect for the dignity of both the pt & caregivers


  • Use of the most appropriate tx c/w pt choice


  • Alleviation of pain & other physical sx


  • Assess & manage the psychological, social, & spiritual difficulties


  • Provide access to therapies that may realistically improve the pt’s QoL, including alternative or nontraditional tx


  • Respect the pt’s right to refuse tx


  • Respect physician’s professional responsibility to d/c tx when appropriate


  • Offer continuity of care (ie, pt should be able to be cared for by his or her care and/or specialist provider)


  • Promote clinical & evidence-based research on providing care at the end of life


  • Provide access to palliative care & hospice care


Palliative Care Family Meeting



  • The main purpose of a family meeting is to improve communication & address any conflicting goals & values between the clinicians, pt, & families. It is a key instrument in sharing medical info, disclosing prognosis, establishing GOC based on the pt’s desires, discussing advance directives & disposition planning in conjunction w/what is medically feasible. This serves as an extra layer of support for the pt, the family, & the medical team.


  • Please see “SPIKES” model for breaking bad news































“SPIKES” Model of Breaking Bad Newsa


Setup


– Analyze key medical info w/ team beforehand & invite key family and IDT members


– Arrange proper physical setting w/quiet private room & make introductions


Pt Perspective


– Ask pt and/or family what is their understanding of the current medical situation


Info/Invitation


– Ask if it would be OK to share the medical info w/the pt & ask how much the pt wants to know


Knowledge


– Be direct, avoid medical jargon, speak clearly but sensitively & use silence after breaking bad news


– “Unfortunately the tests did not reveal what we hoped for”


– “Given what’s happened & what you’re your perspectives & goals are, I would recommend X.”


Empathize/Explore Emotions


w/NURSE” acronymb


Name Emotion: “You seem very upset by the news”


Understand: “Your rxn is completely natural”


Respect: “You have shown a lot of courage in this situation”


Support: “No matter what happens we are going to be here to support you & your family through this”


Explore: “We have discussed a lot. Tell me more about what you are feeling right now.”


Strategize/Summarize


– Summarize next steps, appointments, & reiterate availability of team for pt


– “What questions do you have?”


a (Adapted from Baile et al. Oncologist 2000;5:302-311)

b (Adapted from Pollack et al. J Clin Oncol 2007;25:5748-5752)



Palliative Care Prognostication



  • Physicians tend to be optimistic when determining prognosis & can overestimate by a factor of five (BMJ 2000;320(7233):469-472)


  • Pts & physicians make different care decisions based on prognosis so it is essential that it is as accurate as possible


  • There are certain common s/s typical indicative of end-stage illnesses (Am J Soc 1992;93:663, Cancer 1984;53:2002)



    • Evidence of disease progression


    • Multiple emergency depart visits or hospitalizations in last 6 mos


    • Involuntary wt loss of >10% of BW in previous 6 mos


    • Karnofsky PS of <50%


    • Dependence in at least 3 of 6 ADLs





















Karnofsky Performance Status Scale Definitions Rating (%)


Able to carry on nl activity & to work; no special care needed


100% nl to no complaints, no evidence of disease


90% nl activity, minor s/s


80% nl activity w/effort & signs or sx


Unable to work; but able to live at home & care for most personal needs w/varying amount of assistance


70% cares for self, unable to do nl work


60% requires occasional assistance & frequent medical care


50% requires considerable assistance & frequent medical care


Unable to care for self, requires institutional or hospital care level


40% disabled, & requires special attention


30% severely disabled & hospital admission is indicated although death not imminent


20% very sick, necessary hospital admission requiring active support tx


10% moribund, fatal process progressing rapidly


Oxford Textbook of Palliative Medicine, Oxford University Press. 1993;109.




PAIN MEDICATIONS

Lara A. Dunn

Natalie Moryl


Types of Pain



  • Nociceptive pain



    • Somatic pain: Due to nociceptors activation in body surface or musculoskeletal tissues (ie, met bone disease, soft tissue tumors)


    • Visceral pain: Due to activation of receptors from compression, obstruction, infiltration, ischemia, stretching, or inflammation of the thoracic, abdominal, or pelvic viscera; not well localized (ie, bowel obstruction, bulky liver mets, urinary retention)


  • Neuropathic pain: Due to direct injury or dysfunction of peripheral or CNS

    tissues (ie, compression radiculopathy, postmastectomy & postthoracotomy pain, postherpetic neuralgia)


  • Pain emergency: Pain crisis, spinal cord compression, bone fracture, bowel obstruction, & sev. mucositis

Pain Management at the End of Life is a moral obligation to alleviate pain and unnecessary suffering and is not euthanasia. U.S. Supreme Court Chief Justice Rehnquist, “It is widely recognized that the provision of pain medication is ethically & professionally acceptable even when the tx may hasten the pt’s death if the medication is intended to alleviate pain & sev. discomfort, not to cause death.”


Pain Assessment Scales



  • The pt, not the observer, should complete the scale


  • Measure pain w/a numeric pain intensity scale of 0-10, verbal rating scale, or a visual analog scale can be used for children or adults






Figure 10-1 Wong-Baker FACES Pain Scale. From Hockenberry MJ, Wilson D, Winkelstein ML. Wong’s Essentials of Pediatric Nursing, 7th ed. St. Louis, MO; 2005;1259. © Mosby. Reprinted with permission.


The World Health Organization (WHO) Analgesia Ladder



  • Step 1: For mild pain, use acetaminophen, NSAIDs, or another adjuvant analgesic


  • Step 2: For mild-to-mod. pain, or persistent pain, add a lower potency opioid (codeine) or a low dose of a stronger opioid (morphine)


  • Step 3: For mod. -to-sev. pain, or worsening pain, use strong opioids (morphine, hydromorphone, or fentanyl) (World Health Organization. Cancer Pain Relief with a Guide to Opioid Availability, 2nd ed. Geneva, Switzerland: World Health Organization; 1996)


Opioids Treatment Guidelines



  • For mod.-to-sev. pain (w/close supervision):



    • In opioid naïve, start w/prn IV morphine 2.5-5 mg (or an equivalent); in opioid-tolerant, start w/20% of the daily dose IV every 15 min-2h prn


    • After determining the effective & tolerated daily dose (sum of all doses given w/in the last 24 h), give the opioid around the clock & 10-20% total daily dose q1-2h prn


    • Adjust baseline upward daily based on total amount of prn


  • For chronic use oral route is preferable, then transcutaneous > SC > IV


  • When converting from one opioid to another, reduce the equianalgesic dose by 1/3-1/2 (see table for rotation to methadone)


  • In elderly pts, or those w/sev. liver or renal disease, start 1/2 the usual dose (NCCN Clinical and Practical Guidelines in Oncology. Adult Cancer Pain)



Pain Management in a Patient with Addiction



  • Consider multidisciplinary team approach & a consultation w/an addiction specialist


Opioid Adverse Side Effects



  • Constipation (no tolerance), N/V (tolerance develops in 3-7 d), urinary retention, hypogonadism, sedation, respiratory depression (only after the onset of sedation), myoclonus, delirium, seizures, respiratory arrest & death


Opioid Overdose



  • Manifestations: Respirations <6/min, myoclonic twitching, constricted pupils, skeletal muscle flaccidity, cold or clammy skin


  • Stop administering opioids, wait for the medication to wear off, stimulate pt


  • Naloxone—0.4 mg diluted in 10 mL NS, give 1 mL q5min to reverse respiratory depression or sev. sedation; may need an infusion to counteract the effect of LA methadone or fentanyl patch















































MEDICATION


USUAL STARTING DOSES Adults >50 kg; for opioid naïve patients (*1/2 dose for elderly, or severe renal or liver disease)


PAIN


PARENTERAL


PO/TRANSDERMAL (TD)


MORPHINE


2.5-5 mg SC/IV q3-4h (*1.25-2.5 mg)


7.5-15 mg q3-4h (IR or oral solution) (*2.5-7.5 mg)


MODERATE TO SEVERE


OXYCODONE


Not available


5-10 mg q3-q4h (*2.5 mg)


HYDROMORPHONE


0.2-0.6 mg SC/IV q2-3h (*0.2 mg)


2 mg q3-4 h (*0.5-1 mg)


FENTANYL


25-50 µg IM/IV q1-3h (*12.5-25 µg)


Transdermal patch 12.5 µg/h q72h (contraindicated in opioid naïve)


MEPERIDINE


75 mg SC/IM q2-3h (*25-50 mg) Generally not recommended


50 mg


CODEINE


15-30 mg IM/SC q4h (*7.5-15 mg)


30-60 mg q3-4h (*15-30 mg)


MILD TO MODERATE


HYDROCODONE


NA


5 mg/325 mg acetaminophen q4h (*2.5 mg)


* Info adapted from Drug Facts and Comparisons 2008, 62nd ed., by Facts & Comparisons, 2007, Philadelphia, PA: Lippincott Williams & Wilkins; and Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 6th ed., by the American Pain Society, 2009, Glenview, IL: American Pain Society.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in ONCOLOGY | Comments Off on Pain and Palliative Care

Full access? Get Clinical Tree

Get Clinical Tree app for offline access